📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sunovion

1.1 - Company Overview

Sunovion Logo

Sunovion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutic products discovered, developed and commercialized for central nervous system and respiratory disorders and other illnesses. Portfolio includes Latuda for schizophrenia and bipolar depression; Aptiom for partial-onset seizures; Gemtesa/vibegron for overactive bladder; Myfembree for heavy menstrual bleeding due to uterine fibroids; Orgovyx for advanced prostate cancer; LUNESTA; and XOPENEX.

Products and services

  • Latuda (lurasidone HCl tablets): HCl tablet-form lurasidone treats schizophrenia and bipolar depression in patients, with explicit indications spanning both conditions
  • Gemtesa (vibegron): Vibegron-based medication treats overactive bladder, specifically targeting urge urinary incontinence, urgency, and urinary frequency symptoms in patients
  • Myfembree (relugolix, estradiol, and norethindrone acetate): Combination therapy manages heavy menstrual bleeding associated with uterine fibroids in premenopausal women, leveraging relugolix with estradiol and norethindrone acetate

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sunovion

Prolong Pharmaceuticals Logo

Prolong Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical products and development technologies, including PP-007 (Sanguinate), a PEGylated carboxyhemoglobin bovine product designed to deliver oxygen and carbon monoxide to hypoxic tissues to restore homeostasis and reduce inflammation, and PEGfinity, a PEGylation-based process that enhances the function and stability of therapeutic proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prolong Pharmaceuticals company profile →
Recordati Logo

Recordati

HQ: Italy Website
  • Description: Provider of medications and treatment options across specialty and primary care, consumer healthcare, and rare diseases, focusing on the development and distribution of therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Recordati company profile →
Merck Logo

Merck

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and vaccines for various diseases, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Merck company profile →
Sakura Italia Logo

Sakura Italia

HQ: Italy Website
  • Description: Provider of research and development of natural products for the well-being of mothers and children.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sakura Italia company profile →
Actimis Pharmaceuticals Logo

Actimis Pharmaceuticals

HQ: United States Website
  • Description: Provider of small molecule therapeutics for respiratory and inflammatory disorders; a start-up biopharmaceutical company spun off from Bayer Healthcare AG's respiratory diseases therapeutic research portfolio, founded by Dr. Kevin Bacon.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Actimis Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sunovion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sunovion

2.2 - Growth funds investing in similar companies to Sunovion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sunovion

4.2 - Public trading comparable groups for Sunovion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sunovion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sunovion

What does Sunovion do?

Sunovion is a provider of therapeutic products discovered, developed and commercialized for central nervous system and respiratory disorders and other illnesses. Portfolio includes Latuda for schizophrenia and bipolar depression; Aptiom for partial-onset seizures; Gemtesa/vibegron for overactive bladder; Myfembree for heavy menstrual bleeding due to uterine fibroids; Orgovyx for advanced prostate cancer; LUNESTA; and XOPENEX.

Who are Sunovion's competitors?

Sunovion's competitors and similar companies include Prolong Pharmaceuticals, Recordati, Merck, Sakura Italia, and Actimis Pharmaceuticals.

Where is Sunovion headquartered?

Sunovion is headquartered in United States.

How many employees does Sunovion have?

Sunovion has 1,000 employees 🔒.

When was Sunovion founded?

Sunovion was founded in 2010 🔒.

What sector and industry vertical is Sunovion in?

Sunovion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sunovion

Who are the top strategic acquirers in Sunovion's sector and industry

Top strategic M&A buyers and acquirers in Sunovion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sunovion?

Top strategic M&A buyers groups and sectors for Sunovion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sunovion's sector and industry vertical

Which are the top PE firms investing in Sunovion's sector and industry vertical?

Top PE firms investing in Sunovion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sunovion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sunovion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sunovion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sunovion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sunovion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sunovion?

The key public trading comparables and valuation benchmarks for Sunovion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sunovion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sunovion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sunovion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sunovion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sunovion's' sector and industry vertical?

Access recent funding rounds and capital raises in Sunovion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sunovion